Global Lithium Resources Limited is a lithium exploration company. The primary objective is to seek to expand the Mineral Resources at the Marble Bar Lithium Project, located in the Pilbara region of Western Australia. The Company has had significant exploration success by discovering the Archer lithium deposit and declaration of a maiden Mineral Resource, following three successful RC drilling programs.
NickelX Limited is a nickel-gold explorer who has the right to a promising portfolio of nickel and gold projects in the Albany Fraser Belt. The Company has advanced and well-defined walk-up drill targets for both nickel, with supporting electromagnetic conductors, and gold with high gold surface samples and prospective structural targets delineated. This will allow the Company to rapidly commence drill testing for new discoveries.
Lynch Group Holdings Limited is a vertically integrated value‑added wholesaler and grower of flowers and potted plants into the Australian and Chinese floral markets. The Group’s Australian distribution network consists of four processing facilities servicing more than 2,000 retail stores, while the China business recently established its own processing facility in Shanghai to produce value‑added products at scale for the Chinese domestic market (Shanghai Facility) alongside an existing dedicated processing facility in Kunming focusing on exports to the Group’s Australian business.
Black Canyon Limited is an exploration & development company, has entered into two separate agreements. The first is an agreement to acquire an entity that holds a licence application. The second is an agreement to earn an interest in several exploration licences in Western Australia. These exploration licenses have a focus on manganese and copper. Together, these granted licences and the licence application make up the Carawine Project. The Lofty Range Project currently consists of one exploration licence application.
Mighty Kingdom Limited is an Australian game developer with over 80 staff. Its current in-market games include 9 Shopkins games, LEGO Friends: Heartlake Rush, Snap’s Sugar Slam, Wild Life: Puzzle Story and Ava’s Manor. To-date, Mighty Kingdom has released more than 50 games, with more than 50 million downloads. Within the first half of 2021, is scheduled to release Conan Chop Chop (its first console game) and Sony Pictures’ Peter Rabbit Run and has several other games in development with release schedules 2021/2022.
Australasian Gold Limited is a gold mine exploer, established to identify and explore gold and base metal projects, primarily in early-stage exploration projects in Australia. The Company through its wholly-owned subsidiary Pure Mining Pty Limited has acquired two projects from unrelated third parties (May Queen and Mt Clermont), has been granted the southern extension of the May Queen gold project in Queensland, and has applied for a third project in Western Australia (Fairview).
Iceni Gold Limited is a gold explorer company. Its key project is the 14 Mile Well Project located in the Laverton region of Western Australia. The Company acquired most of the tenements from MCA, a company controlled by Brian Rodan. The Project comprises 5 granted exploration licences, 155 granted prospecting licences, and 1 granted mining lease. It also includes applications for a further 6 prospecting licences, 3 mining leases (overlapping the area of existing granted prospecting licences).
Propell Holdings Limited is a digital-only, customer-centric FinTech platform focused on payments and lending for the small to medium enterprise segment, with multiple financial products to help them manage and optimise their cash flow. Current financial products include a lending product that provides business owners with funding, all facilitated through Propell’s proprietary credit technology and a Transactional Product to enable businesses to accept various emerging payment methods online and instore.
Island Pharmaceuticals Limited is a drug research and repurposing company focused on developing preventative or therapeutic drugs for viral infections. The company has a wholly-owned subsidiary Isla Pharmaceuticals, Inc. (Isla US), and it is currently advancing its lead drug candidate “Isla101” towards a Phase 2 clinical trial in dengue infected subjects, which has the potential to be used to prevent or treat several viruses, including dengue, Zika and chikungunya, and other diseases rife in tropical climates. It could potentially displace vaccines.